Steven Cohen Corcept Therapeutics Inc Put Options Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $8.39 Million - $13.7 Million	-500,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $6.23 Million - $9.99 Million	500,000 New	500,000 $8.7 Million
Q3 2018 Nov 14, 2018	SELL	$12.27 - $15.65 $4.91 Million - $6.26 Million	-400,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$15.3 - $19.69 $6.12 Million - $7.88 Million	400,000 New	400,000 $6.29 Million

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.82B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.